Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. [electronic resource] by
- Del Campo, J M
- Roszak, A
- Bidzinski, M
- Ciuleanu, T E
- Hogberg, T
- Wojtukiewicz, M Z
- Poveda, A
- Boman, K
- Westermann, A M
- Lebedinsky, C
Producer: 20100108
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
10.
|
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study. [electronic resource] by
- Brodowicz, T
- Ciuleanu, T E
- Radosavljevic, D
- Shacham-Shmueli, E
- Vrbanec, D
- Plate, S
- Mrsic-Krmpotic, Z
- Dank, M
- Purkalne, G
- Messinger, D
- Zielinski, C C
Producer: 20131211
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
11.
|
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. [electronic resource] by
- Peeters, M
- Price, T J
- Cervantes, A
- Sobrero, A F
- Ducreux, M
- Hotko, Y
- André, T
- Chan, E
- Lordick, F
- Punt, C J A
- Strickland, A H
- Wilson, G
- Ciuleanu, T E
- Roman, L
- Van Cutsem, E
- Tian, Y
- Sidhu, R
Producer: 20140811
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|
|
12.
|
Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study. [electronic resource] by
- Tabernero, J
- Hozak, R R
- Yoshino, T
- Cohn, A L
- Obermannova, R
- Bodoky, G
- Garcia-Carbonero, R
- Ciuleanu, T-E
- Portnoy, D C
- Prausová, J
- Muro, K
- Siegel, R W
- Konrad, R J
- Ouyang, H
- Melemed, S A
- Ferry, D
- Nasroulah, F
- Van Cutsem, E
Producer: 20190408
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 29
Availability: No items available.
|
|
13.
|
Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study. [electronic resource] by
- Ferris, R L
- Haddad, R
- Even, C
- Tahara, M
- Dvorkin, M
- Ciuleanu, T E
- Clement, P M
- Mesia, R
- Kutukova, S
- Zholudeva, L
- Daste, A
- Caballero-Daroqui, J
- Keam, B
- Vynnychenko, I
- Lafond, C
- Shetty, J
- Mann, H
- Fan, J
- Wildsmith, S
- Morsli, N
- Fayette, J
- Licitra, L
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|